ClearBridge Investments
ALXN

ClearBridge Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,866,154
Closed -$917M 835
2020
Q4
$917M Sell
5,866,154
-542,076
-8% -$84.7M 0.71% 30
2020
Q3
$733M Sell
6,408,230
-491,377
-7% -$56.2M 0.63% 40
2020
Q2
$774M Buy
6,899,607
+351,389
+5% +$39.4M 0.7% 35
2020
Q1
$588M Buy
6,548,218
+185,429
+3% +$16.6M 0.64% 46
2019
Q4
$686M Buy
6,362,789
+129,281
+2% +$13.9M 0.57% 52
2019
Q3
$611M Buy
6,233,508
+227,311
+4% +$22.3M 0.53% 54
2019
Q2
$787M Buy
6,006,197
+196,164
+3% +$25.7M 0.68% 36
2019
Q1
$785M Buy
5,810,033
+665,574
+13% +$90M 0.69% 33
2018
Q4
$501M Sell
5,144,459
-33,698
-0.7% -$3.28M 0.51% 53
2018
Q3
$720M Buy
5,178,157
+691,390
+15% +$96.1M 0.62% 37
2018
Q2
$557M Buy
4,486,767
+442,473
+11% +$54.9M 0.46% 59
2018
Q1
$451M Buy
4,044,294
+502,423
+14% +$56M 0.43% 74
2017
Q4
$424M Buy
3,541,871
+307,117
+9% +$36.7M 0.39% 82
2017
Q3
$454M Buy
3,234,754
+171,703
+6% +$24.1M 0.44% 68
2017
Q2
$373M Buy
3,063,051
+414,280
+16% +$50.4M 0.37% 79
2017
Q1
$321M Buy
2,648,771
+377,098
+17% +$45.7M 0.32% 94
2016
Q4
$278M Buy
2,271,673
+581,562
+34% +$71.2M 0.31% 99
2016
Q3
$207M Buy
1,690,111
+297,204
+21% +$36.4M 0.23% 110
2016
Q2
$163M Buy
1,392,907
+740,287
+113% +$86.4M 0.19% 124
2016
Q1
$90.9M Buy
652,620
+567,165
+664% +$79M 0.11% 175
2015
Q4
$16.3M Buy
85,455
+19,662
+30% +$3.75M 0.02% 436
2015
Q3
$10.3M Buy
65,793
+10,259
+18% +$1.6M 0.01% 489
2015
Q2
$10M Buy
55,534
+42,673
+332% +$7.71M 0.01% 502
2015
Q1
$2.23M Buy
12,861
+944
+8% +$164K ﹤0.01% 673
2014
Q4
$2.21M Buy
11,917
+195
+2% +$36.1K ﹤0.01% 694
2014
Q3
$1.94M Buy
11,722
+1,471
+14% +$244K ﹤0.01% 705
2014
Q2
$1.6M Sell
10,251
-313
-3% -$48.9K ﹤0.01% 692
2014
Q1
$1.61M Sell
10,564
-3,747
-26% -$570K ﹤0.01% 695
2013
Q4
$1.9M Buy
14,311
+1,611
+13% +$214K ﹤0.01% 667
2013
Q3
$1.48M Sell
12,700
-5,590
-31% -$649K ﹤0.01% 672
2013
Q2
$1.69M Buy
+18,290
New +$1.69M ﹤0.01% 639